Skip to main content
SpringerLink
Log in
Book cover

Infections à papillomavirus pp 3–45Cite as

Infections génitales à HPV. Bases fondamentales

  • Chapter

  • 387 Accesses

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Bosch FX, Lorincz A, Munoz N et al. (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244–65

    PubMed  CAS  Google Scholar 

  2. Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1): 1–17. Review

    Article  PubMed  CAS  Google Scholar 

  3. de Villiers EM, Fauquet C, Broker TR et al. (2004) Classification of papillomaviruses. Virology 20; 324(1): 17–27. Review

    Article  PubMed  CAS  Google Scholar 

  4. Howley PM, Lowy DR (2001) Papillomaviruses and their replication. In: Fields Virology, Knipe DM, Howley PM et al. (eds), 2: 2197–330, Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  5. Munger K, Baldwin A, Edwards KM et al. (2004) Mechanisms of human papillomavirus induced oncogenesis. J. Virol 78: 11451–60

    Article  PubMed  CAS  Google Scholar 

  6. Schiffman MH, Bauer HM, Hoover RN et al. (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 16; 85(12): 958–64

    PubMed  CAS  Google Scholar 

  7. Bosch FX, Manos MM, Munoz N et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 7; 87(11): 796–802

    PubMed  CAS  Google Scholar 

  8. Kjaer SK, van den Brule AJ, Bock JE et al. (1996) Human Papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1: 65(5): 601–6

    Article  PubMed  CAS  Google Scholar 

  9. zur Hausen H. (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 3; 92(9): 690–8. Review

    Article  PubMed  Google Scholar 

  10. Walboomers JM, Jacobs MV, Manos MM et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1): 12–9

    Article  PubMed  CAS  Google Scholar 

  11. Munoz MD, Bosch MD, de Sanjosé MD et al. for the International Agency for research on Cancer Multicenter Cervical Cancer Study Group (2003) Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med 348: 518–27

    Article  PubMed  Google Scholar 

  12. Munoz N, Bosch FX, Castellsague X et al. (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 20; 111(2): 278–85

    Article  PubMed  CAS  Google Scholar 

  13. Hildesheim A, Gravitt P, Schiffman MH et al. (1993) Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis. 20(5): 279–85

    Article  PubMed  CAS  Google Scholar 

  14. Anderson RM (1999) Transmission dynamics of sexually transmitted infections. In: Holmes KK, Mardh P-A, Sparling PF et al. eds. Sexually Transmitted Diseases. New York, McGraw-Hill, 25–37

    Google Scholar 

  15. Franco E, Villa L, Ruiz A, Costa M (1995) Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high risk types. J Infect Dis 172: 756–63

    PubMed  CAS  Google Scholar 

  16. Winer RL, Kiviat NB, Hughes JP et al. (2005) Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis. 1; 191(5): 731–8. Epub 2005 Jan 21

    Article  PubMed  Google Scholar 

  17. Kjaer S, Van den Brule A, Bock J et al. (1997) Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomar 6: 799–805

    CAS  Google Scholar 

  18. Collins S, Mazloomzadeh S, Winter H et al. (2002) High incidence of cervical human papillomavirus infection in women during their first sexual relationship, BJOG, 109(1): 96–8

    Google Scholar 

  19. Winer RL, Lee SK, Hughes JP et al. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 1;157(3):218–26. Erratum in: Am J Epidemiol 1; 157(9): 858

    Article  PubMed  Google Scholar 

  20. Remmink AJ, Walboomers JM, Helmerhorst TJ et al. (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 4; 61(3): 306–11

    PubMed  CAS  Google Scholar 

  21. Ho GY, Biermal R, Beardsley L et al. (1998) Natural history of cervicovaginal papillomavirus infection in young women. N engl J Med 338: 423–8.

    Article  PubMed  CAS  Google Scholar 

  22. Richardson H, Kelsall G, Tellier P et al. (2003) The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiology, Biomarkers & Prevention 12: 485–490

    Google Scholar 

  23. Clifford GM, Smith JS, Aguado T, Franceschi S (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a metaanalysis. Br J Cancer 7; 89(1): 101–5

    Article  PubMed  CAS  Google Scholar 

  24. Castle PE, Schiffman M, Scott DR et al. (2005) Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiol Biomarkers Prev 14(5): 1311–16

    Article  PubMed  Google Scholar 

  25. Ferlay L, Bray F, Pisani P, Parkin M (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide IARC CanceBase. No5, version2.0. Lyon IARC Press

    Google Scholar 

  26. Wang SS, Sherman ME, Hildesheim A et al. (2004) Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer 1; 100(5): 1035–44

    Article  PubMed  Google Scholar 

  27. Quinn M, Babb P, Jones J, Allen E (1999) Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 3; 318(7188): 904–8

    PubMed  CAS  Google Scholar 

  28. Sawaya GF, Kerlikowske K, Lee NC et al. (2000) Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol 96(2): 219–23

    Article  PubMed  CAS  Google Scholar 

  29. Melkert PW, Hopman E, van den Brule AJ et al. (1993) Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1; 53(6): 919–23

    Article  PubMed  CAS  Google Scholar 

  30. Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 5; 102(5A): 3–8

    Article  PubMed  CAS  Google Scholar 

  31. Schiffman M, Krüger Kjaer S (2003) Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Institute Monographs; 31: 14–9

    Google Scholar 

  32. Koutsky LA, Holmes KK, Critchlow CW et al. (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to Papillomavirus infection. N Eng J Med 327: 1272–8

    Article  CAS  Google Scholar 

  33. Monsonego J (2003) Infections génitales à papillomavirus (HPV): mise au point, nouveaux concepts et applications. In: Michel Segondy «Infections virales sexuellement transmissibles » Guide Médi/BIO; 149: 176

    Google Scholar 

  34. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ et al. (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 3; 354(9172): 20–5

    Article  PubMed  CAS  Google Scholar 

  35. Lajous M, Mueller N, Cruz-Valdéz A et al. (2005) Determinants of prevalence, acquisition, and persistence of human papillomavirus in health Mexican military men. Cancer Epidemiology, Biomarkers & Prevention 14: 1710–6

    Article  CAS  Google Scholar 

  36. Shin HR, Franceschi S, Vaccarella S et al. (2004) Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. Journal of Infectious Diseases 190: 468–76

    Article  PubMed  Google Scholar 

  37. Lazcano-Ponce E, Herrero R, Munoz N et al. (2001) High prevalence of human papillomavirus infection in Mexican males: Comparative study of penile-urethral swabs and urine samples. Sexually Transmitted Diseases 28: 277–80

    PubMed  CAS  Google Scholar 

  38. Baldwin S, Wallace D, Papenfuss M et al. (2003) Human papillomavirus infection in men attending a sexually transmitted disease clinic. Journal of Infectious Diseases 187: 1064–70

    Article  PubMed  Google Scholar 

  39. Baldwin S, Wallace D, Papenfuss M et al. (2004) Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sexually Transmitted Diseases 31: 601–7

    Article  PubMed  Google Scholar 

  40. Brown D, Shew M, Qadadri B et al. (2005) A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191: 182–92

    Article  PubMed  Google Scholar 

  41. Moscicki AB, Shiboski S, Broering J et al. (1998) The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. Journal of Pediatrics 132: 277–84

    Article  PubMed  CAS  Google Scholar 

  42. Woodman CB, Collins S, Winter H et al. (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357: 1831–6

    Article  PubMed  CAS  Google Scholar 

  43. Rozendaal L, Westerga J, van der Linden JC et al. (2000) PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN 3 in women with normal cytology and borderline changes. J Clin Pathol 53(8): 606–11

    Article  PubMed  CAS  Google Scholar 

  44. Clifford GM, Gallus S, Herrero R et al. (2005) IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 17–23; 366(9490):991–8

    Article  PubMed  CAS  Google Scholar 

  45. Clifford GM, Rana RK, Franceschi S et al. (2005) Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14(5): 1157–64. Review

    Article  PubMed  Google Scholar 

  46. Khan MJ, Castle PE, Lorincz AT et al. (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 20; 97(14): 1072–9

    PubMed  Google Scholar 

  47. Franceschi S (2005) The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res 166: 277–97. Review

    PubMed  Google Scholar 

  48. Castle PE, Solomon D, Schiffman M, Wheeler CM for the ALTS Group (2005) Human Papillomavirus Type 16 infections and 2-Year absolute risk of cervical precancer in Women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 97: 1066–71

    Article  PubMed  Google Scholar 

  49. Castle PE, Schiffman M, Herrero R et al. (2005) A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 1; 191(11): 1808–16. Epub 2005 May 2

    Article  PubMed  Google Scholar 

  50. Richardson H, Franco E, Pintos J et al. (2000) Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal university students. Sexually Transmitted Diseases 27: 79–86

    Article  PubMed  CAS  Google Scholar 

  51. Giuliano A, Papenfuss M, Abrahamsen M, Inserra P (2002) Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiology, Biomarkers & Prevention 11: 930–4

    Google Scholar 

  52. Herrero R, Castle P, Schiffman M et al. (2005) Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191: 1796–1807

    Article  PubMed  Google Scholar 

  53. Rousseau M, Franco E, Villa L et al. (2000) A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol Biomar 9: 469–76

    CAS  Google Scholar 

  54. Ho GY, Burk RD, Klein S et al. (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365–71

    PubMed  CAS  Google Scholar 

  55. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ et al. (2001) Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 24; 358(9295): 1782–3

    Article  PubMed  CAS  Google Scholar 

  56. Schlecht NF, Kulaga S, Robitaille J et al. (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 26; 286(24): 3106–14

    Article  PubMed  CAS  Google Scholar 

  57. Cuschieri KS, Cubie HA, Whitley MW et al. (2005) Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 58(9): 946–50

    Article  PubMed  CAS  Google Scholar 

  58. Dalstein V, Riethmuller D, Pretet JL et al. (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 1; 106(3): 396–403

    Article  PubMed  CAS  Google Scholar 

  59. Bory JP, Cucherousset J, Lorenzato M et al. (2002) Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer 10; 102(5): 519–25

    Article  PubMed  CAS  Google Scholar 

  60. Kjaer SK, Munk C, Winther JF et al. (2005) Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev. 14(6):1528–33

    Article  PubMed  Google Scholar 

  61. Wallin KL, Wiklund F, Angstrom T et al. (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 25; 341(22): 1633

    Article  PubMed  CAS  Google Scholar 

  62. Wang SS, Hildesheim A (2003) Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 31: 35–40

    PubMed  CAS  Google Scholar 

  63. Cuzick J (2002) Role of HPV testing in clinical practice. Virus Res 89(2):263–9

    Article  PubMed  CAS  Google Scholar 

  64. Castellsague X, Bosch FX, Munoz M (2002) Environmental cofactors in HPV carcinogenesis. Virus Res 89: 191–9

    Article  PubMed  CAS  Google Scholar 

  65. Monsonego J (1996) Papillomavirus et cancer du col de l’utérus. Médecine/Sciences 12: 733–42

    Google Scholar 

  66. Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12: 186–92

    PubMed  CAS  Google Scholar 

  67. Nasiell K, Nasiell M, Vaclavinkova V (1983) Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 61: 609–14

    PubMed  CAS  Google Scholar 

  68. Nasiell K, Roger V, Nasiell M (1986) Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol, 67(5): 665–9

    Article  PubMed  CAS  Google Scholar 

  69. Holowaty P, Miller AB, Rohan T, To T (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Int 91: 252–8

    Article  CAS  Google Scholar 

  70. Barron BA, Richart RM (1968) A statistical model of the natural history of cervical carcinoma based on a prospective study of 557 cases. J Natl Cancer Inst 41(6): 1343–53

    PubMed  CAS  Google Scholar 

  71. Richart RM, Barron BA (1969) A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 105: 386–393

    PubMed  CAS  Google Scholar 

  72. IARC Working Group, Human Papillomavirus (1995) IARC Monographson the evaluation of carcinogenics risk to humans Vol.64. Lyon: International Agency for Research on Cancer

    Google Scholar 

  73. Richardson H, Abrahamowicz M, Tellier PP et al. (2005) Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev 14(5): 1149–56

    Article  PubMed  Google Scholar 

  74. Giuliano A, Harris R, Sedjo R et al. (2002) Incidence, prevalence and clearance of type-specific human papillomavirus infections: The Young Women’s Health Study. Journal of Infectious Diseases 186: 462–9

    Article  PubMed  Google Scholar 

  75. Frazer I. H, Thomas R, Zhou J et al. (1999) Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev 168: 131

    Article  PubMed  CAS  Google Scholar 

  76. Da Silva DM, Velders MP, Nieland JD et al. (2001) Physical interaction of human papillomavirus virus-like particles with immune cells. Int Immunol 13: 633

    Article  PubMed  Google Scholar 

  77. Charbonnier AS, Kohrgruber N, Kriehuber E et al. (1999) Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J Exp Med 190: 1755

    Article  PubMed  CAS  Google Scholar 

  78. Coleman N, Birley HD, Renton AM et al. (1994) Immunological events in regressing genital warts. Am J Clin Pathol 102: 768

    PubMed  CAS  Google Scholar 

  79. Ghosh AK, Moore M (1992) Tumour-infiltrating lymphocytes in cervical carcinoma. Eur J Cancer 28A: 1910

    Article  PubMed  CAS  Google Scholar 

  80. Evans EM, Man S, Evans AS, Borysiewicz LK (1997) Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res 57: 2943

    PubMed  CAS  Google Scholar 

  81. Hohn H, Pilch H, Gunzel S et al. (2000) Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer. J Virol 74: 6632

    Article  PubMed  CAS  Google Scholar 

  82. Hohn H, Pilch H, Gunzel S et al. (1999) CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7. J Immunol 163: 5715

    PubMed  CAS  Google Scholar 

  83. Hong K, Greer CE, Ketter N et al. (1997) Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts. J Virol 71: 6427

    PubMed  CAS  Google Scholar 

  84. Evans C, Bauer ST, Grubert C et al. (1996) HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions. Cancer Immunol Immunother 42: 151

    Article  PubMed  CAS  Google Scholar 

  85. Nakagawa M, Stites DP, Farhat S et al. (1997) Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis 175: 927

    Article  PubMed  CAS  Google Scholar 

  86. Ressing ME., van Driel WJ, Celis E et al. (1996) Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope. Cancer Res 56: 582

    PubMed  CAS  Google Scholar 

  87. Rangel R, Rocha, L, Ramirez JL et al. (1995) Generation of memory CD4+, CD8+, CD45RO+ and CD16-lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture. Eur Cytokine Netw 6: 195

    PubMed  CAS  Google Scholar 

  88. Valdespino V, Gorodezky C, Ortiz V et al. (2005) HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients. Gynecol Oncol 96: 92

    Article  PubMed  Google Scholar 

  89. Kadish AS, Ho GY, Burk RD et al. (1997) Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 89: 1285

    Article  PubMed  CAS  Google Scholar 

  90. Hopfl R, Heim K, Christensen N et al. (2000) Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet 356:1985

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France, Paris

About this chapter

Cite this chapter

(2006). Infections génitales à HPV. Bases fondamentales. In: Infections à papillomavirus. Springer, Paris. https://doi.org/10.1007/2-287-33480-7_1

Download citation

  • DOI: https://doi.org/10.1007/2-287-33480-7_1

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-33479-5

  • Online ISBN: 978-2-287-33480-1

Publish with us

Policies and ethics

Search

Navigation